Cargando…
Impact of Waiting Response Evaluation to First-Line Systemic Therapy before Considering Local Ablative Therapy in Metastatic Non-Small-Cell Lung Cancer
SIMPLE SUMMARY: Stereotactic radiotherapy (SRT) is becoming increasingly important in managing metastatic non-small-cell lung cancer (mNSCLC). However, the optimal timing of SRT in relation to systemic treatment remains unclear. Herein, we aimed to determine whether waiting response evaluation to fi...
Autores principales: | Belaidi, Lahcene, Wang, Pascal, Quintin, Kevin, Durdux, Catherine, Giroux-Leprieur, Etienne, Giraud, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649273/ https://www.ncbi.nlm.nih.gov/pubmed/37958302 http://dx.doi.org/10.3390/cancers15215127 |
Ejemplares similares
-
Do We Need to Delineate the Humeral Head in Breast Cancer Patients?
por: Belaidi, Lahcene, et al.
Publicado: (2022) -
Acute generalized exanthematous pustulosis caused by gemcitabine after nivolumab in metastatic lung adenocarcinoma followed by a dramatic tumor response: A case report
por: Magdelaine, Pierre, et al.
Publicado: (2022) -
Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021) -
Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives
por: Leprieur, Etienne Giroux, et al.
Publicado: (2016) -
Posterior Reversible Encephalopathy Occurring During Treatment With Palbociclib
por: Belaidi, Lahcene, et al.
Publicado: (2021)